13F

Stock

Anika Therapeutics, Inc.

ANIK · held by 7 managers

Reported value

$4.4M

Holders

7

+0 new · −0 exited

Holders’ est. mark

−$37.9K

Price effect on 2 books still in the name

Largest holder

$3.71M

MORGAN STANLEY

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
MORGAN STANLEY394.7K$3.71MHeld
BARCLAYS PLC32.1K$301.5K−$37.8KCut−$72.9K
BANK OF AMERICA CORP /DE/29.7K$279KHeld
TUDOR INVESTMENT CORP ET AL11.4K$106.7KHeld
Essential Partners LLC319$3K−$6Added$2.95K
IFP Advisors, Inc23$216Held
Allworth Financial LP11$104Held

Positions as of Q3 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.